Literature DB >> 1565399

Conservative surgical management of dysgerminoma concomitant with pregnancy.

R E Buller1, V Darrow, A Manetta, M Porto, P J DiSaia.   

Abstract

Three cases of pure dysgerminoma concomitant with pregnancy were managed by conservative surgery and term delivery. One woman with advanced disease received chemotherapy for the last trimester. Tumor response, measured by normalization of the serum tumor markers CA 125 and lactic dehydrogenase, was confirmed by magnetic resonance imaging.

Entities:  

Mesh:

Year:  1992        PMID: 1565399

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

Review 1.  Ovarian dysgerminoma in pregnancy: A case report and literature review.

Authors:  Yuanyuan Chen; Ying Luo; Cha Han; Wenyan Tian; Wen Yang; Yingmei Wang; Fengxia Xue
Journal:  Cancer Biol Ther       Date:  2018-04-25       Impact factor: 4.742

Review 2.  A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Authors:  Stergios Boussios; Michele Moschetta; Konstantina Tatsi; Alexandros K Tsiouris; Nicholas Pavlidis
Journal:  J Adv Res       Date:  2018-03-06       Impact factor: 10.479

Review 3.  Efficacy and Safety of Platinum-Based Chemotherapy for Ovarian Cancer During Pregnancy: A Systematic Review and Meta-Analysis.

Authors:  Yaping Pei; Yuanfeng Gou; Na Li; Xiaojuan Yang; Xue Han; Liu Huiling
Journal:  Oncol Ther       Date:  2021-12-04

Review 4.  Uncommon Metastasis of Ovarian Dysgerminoma: A Case Report and Review of the Literature.

Authors:  Mihaela Camelia Tîrnovanu; Irina Daniela Florea; Adina Tănase; Bogdan Florin Toma; Elena Cojocaru; Carmen Ungureanu; Ludmila Lozneanu
Journal:  Medicina (Kaunas)       Date:  2021-05-27       Impact factor: 2.430

Review 5.  Pregnancy with giant ovarian dysgerminoma: A case report and literature review.

Authors:  Xi-Wen Zhang; Li-Rong Zhai; Dong-Wei Huang; Zhen-De Jiang; Tong Yu; Shu-Yan Liu; Man-Hua Cui
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.